Avalon GloboCare (ALBT) News Today → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free ALBT Stock Alerts $0.28 -0.02 (-5.30%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 12, 2024 | americanbankingnews.comShort Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Drops By 64.1%April 25, 2024 | finance.yahoo.comAvalon GloboCare Corp. (ALBT)April 23, 2024 | proactiveinvestors.comAvalon GloboCare launches KetoAir breathalyzer in the USApril 22, 2024 | globenewswire.comAvalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 ConferenceApril 16, 2024 | msn.comALBT Stock Earnings: Avalon Globocare Reported Results for Q4 2023March 28, 2024 | proactiveinvestors.comAvalon GloboCare extends exclusive distribution agreement for KetoAir breathalyzerMarch 28, 2024 | globenewswire.comAvalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European UnionDecember 18, 2023 | finance.yahoo.comAvalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the USNovember 16, 2023 | morningstar.comAvalon Globocare Corp ALBTOctober 18, 2023 | finance.yahoo.comAvalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic KetoacidosisOctober 6, 2023 | benzinga.comApple Approves Use of Avalon GloboCare's KetoAir Mobile ApplicationOctober 6, 2023 | finance.yahoo.comShareholders May Be A Bit More Conservative With Avalon GloboCare Corp.'s (NASDAQ:ALBT) CEO Compensation For NowOctober 4, 2023 | proactiveinvestors.comAvalon GloboCare debuts KetoAir app on Apple App StoreOctober 4, 2023 | finance.yahoo.comApple Approves Use of Avalon GloboCare’s KetoAir Mobile ApplicationSeptember 27, 2023 | theglobeandmail.comNews Brief: Avalon GloboCare Corp.September 13, 2023 | proactiveinvestors.comAvalon GloboCare shares spike on Laboratory Services MSO acquisitionsSeptember 5, 2023 | proactiveinvestors.comAvalon GloboCare shares surge as recent momentum continuesAugust 30, 2023 | ca.finance.yahoo.comStocks in play: Avalon GloboCare Corp.August 30, 2023 | proactiveinvestors.comAvalon GloboCare investee LSM launches innovative lab test for tuberculosisAugust 30, 2023 | finance.yahoo.comEXCLUSIVE: Diagnostics Provider Avalon GloboCare's Subsidiary Launches New Laboratory Test For TuberculosisAugust 21, 2023 | proactiveinvestors.comAvalon GloboCare announces Laboratory Services MSO’s expansion into Arizona; shares riseAugust 21, 2023 | proactiveinvestors.comAvalon GloboCare announces Laboratory Services MSO’s expansion into ArizonaAugust 21, 2023 | finance.yahoo.comAvalon’s Laboratory Services MSO Announces Expansion into ArizonaAugust 16, 2023 | finance.yahoo.comAvalon GloboCare Second Quarter 2023 Earnings: US$0.25 loss per share (vs US$0.23 loss in 2Q 2022)July 24, 2023 | proactiveinvestors.comAvalon GloboCare investee buys Houston-based lab testing facilityJuly 19, 2023 | marketwatch.comAvalon GloboCare Shares Rise 12% After Lab Services Agreement With GeneXJuly 19, 2023 | finance.yahoo.comAvalon GloboCare’s Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 StatesJuly 12, 2023 | proactiveinvestors.comAvalon GloboCare says 2023 will be ‘pivotal year’ as it executes new commercial strategyJuly 10, 2023 | finance.yahoo.comAvalon GloboCare Provides Update on New Commercial StrategyJune 14, 2023 | seekingalpha.comIndustrial Logistics Properties Trust among financials gainers, Qudian in losersMay 16, 2023 | benzinga.comAvalon Globocare Stock (NASDAQ:ALBT), Insider Trading ActivityApril 27, 2023 | proactiveinvestors.comAvalon GloboCare highlights the 2022 results of its latest investment, Laboratory Services MSOApril 27, 2023 | finance.yahoo.comAvalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022April 17, 2023 | proactiveinvestors.comAvalon GloboCare to launch its KetoAir breathalyzer device in North America at upcoming conferenceApril 17, 2023 | finance.yahoo.comAvalon GloboCare Announces Commercial Launch of KetoAir Breathalyzer at the KetoCon Austin 2023 ConferenceApril 11, 2023 | proactiveinvestors.comAvalon GloboCare inks deal with Qi Diagnostics for distribution of KetoAir breathalyzerApril 11, 2023 | finance.yahoo.comAvalon GloboCare Signs Agreement with Qi Diagnostics to Exclusively Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, U.K. and European UnionFebruary 28, 2023 | seekingalpha.comALBT Avalon GloboCare Corp.February 13, 2023 | msn.comAvalon GloboCare acquires 40% interest in Laboratory Services MSO for $21MFebruary 13, 2023 | proactiveinvestors.comAvalon GloboCare excited as it closes earnings accretive investment in testing firmFebruary 13, 2023 | finance.yahoo.comAvalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory CompanyJanuary 17, 2023 | proactiveinvestors.comAvalon GloboCare says it has been issued with a US patent for multiple novel QTY-code modified cytokine and chemokine protein receptor moleculesJanuary 17, 2023 | finance.yahoo.comAvalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor MoleculesJanuary 11, 2023 | proactiveinvestors.comAvalon GloboCare appoints Lourdes Felix, CEO of a premier addiction treatment company, to its boardJanuary 11, 2023 | finance.yahoo.comAvalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of DirectorsJanuary 6, 2023 | marketbeat.comTrading was temporarily halted for "ALBT" at 09:01 AM with a stated reason of "LULD pause."January 5, 2023 | marketbeat.comTrading was temporarily halted for "ALBT" at 12:01 PM with a stated reason of "LULD pause."January 5, 2023 | marketbeat.comTrading was temporarily halted for "ALBT" at 12:01 PM with a stated reason of "LULD pause."January 3, 2023 | finanznachrichten.deAvalon GloboCare Corp.: Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map TechnologyJanuary 3, 2023 | proactiveinvestors.comAvalon GloboCare reveals deployment of breakthrough fusion gene map technology Get Avalon GloboCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter. Email Address 4 Cryptos BETTER than Bitcoin (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 ALBT Media Mentions By Week ALBT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALBT News Sentiment▼0.000.42▲Average Medical News Sentiment ALBT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALBT Articles This Week▼00▲ALBT Articles Average Week Get Avalon GloboCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Finch Therapeutics Group News Today Eloxx Pharmaceuticals News Today Kiromic BioPharma News Today TC Biopharm News Today Windtree Therapeutics News Today TRACON Pharmaceuticals News Today Scinai Immunotherapeutics News Today Acorda Therapeutics News Today Fresh Tracks Therapeutics News Today Palisade Bio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALBT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding Avalon GloboCare Corp. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
